思泰瑞医疗 STE 深 沪
交易中 10-09 10:33:59 美东时间
212.62
+1.860
+0.88%
华盛通- 最 高213.25
- 今 开210.80
- 成交量 2.56万股
- 最 低 209.02
- 昨 收 210.76
- 总市值 2073.05万
- 52周最高 267.49
- 市盈率 静 26.83
- 换手率 0.03%
- 52周最低 193.82
- 委 比 9.09%
- 总股本 9.75万
- 历史最高 267.49
- 量 比 0.29
- 振 幅 2.01%
- 历史最低 7.56
- 每 手 1
- 风险率 18.98%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Full Transcript: Steris Q1 2027 Earnings Call
Steris (NYSE:STE) held its first-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and transcripts, visit https://www.benzinga.com/apis/. Access the full call at https://edge.media-...
今天 16:25
Top 3 Health Care Stocks That May Rocket Higher In September
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give...
09-21 18:01
Recent Report Shows That Rep. Jared Moskowitz Sold Up to $30K Worth of Steris Stock
An official report on August 27, 2026 reveals Representative Jared Moskowitz's recent sale of Steris (NYSE:STE) stock, valued between $2,002 and $30,000. The transaction took place on July 13, 2026, as per the August filing. At this time, Steris shares are trading down 0.63% at $233.31. What Represe...
08-28 23:00
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
财报速睇 | 思泰瑞医疗 2026财年Q2营收14.93亿美元，同比增长7.3%；归母净利润2.00亿美元，同比增长12.8%
华盛资讯8月9日讯，思泰瑞医疗公布2026财年Q2业绩，公司Q2营收14.93亿美元，同比增长7.3%，归母净利润2.00亿美元，同比增长12.8%。
08-09 05:01
财报速睇 | 思泰瑞医疗 2026财年Q2营收14.93亿美元，同比增长7.3%；归母净利润2.00亿美元，同比增长12.8%
华盛资讯8月8日讯，思泰瑞医疗公布2026财年Q2业绩，公司Q2营收14.93亿美元，同比增长7.3%，归母净利润2.00亿美元，同比增长12.8%。
08-08 04:19
Piper Sandler Reiterates Overweight on Steris, Raises Price Target to $275
Piper Sandler analyst Jason Bednar reiterates Steris (NYSE:STE) with a Overweight and raises the price target from $270 to $275.
08-08 01:16
STERIS Plans $600M Investment To Construct Formulated Chemistries Manufacturing And Distribution Center Of Excellence In North Carolina
STERIS plc (NYSE:STE) ("STERIS" or the "Company") today announced that it will be investing $600 million to build a formulated chemistries manufacturing and distribution Center of Excellence in North Carolina, near the Raleigh-Durham Research Triangle region. The facility will serve as a central hub...
08-05 20:46
思泰瑞医疗（STE）获大摩维持买入评级 目标价下调至275美元
经济观察网 思泰瑞医疗（STE）获摩根士丹利维持买入评级，目标价被下调至275美元，仍较当前股价高出约20%。 机构观点： 摩根士丹利7月28日下调目标价，从...
08-03 05:54
美股大行评级 | 潜在涨幅129.15%！HC Wainwright & Co.升Q32 Bio(QTTB)目标价至36美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Q32 Bio"买入"评级，目标价从13美元升至36美元；Chardan Capital：维持ProMIS Neurosciences"买入"评级，目标价从20美元升至33美元
07-29 11:37
